ADORA2A and Parkinson disease: A major new finding was the observation that this released ATP-CD73-A2AR pathway controlling corticostriatal LTP is overfunctioning in the presymptomatic phase of PD, i.e., 7 days after the administration of 6-OHDA when mood modifications are already present but motor dysfunction is still not significant [21, 22].